Heptabarbital

Jump to: navigation, search
Heptabarbital
Heptabarb Wiki str.png
Clinical data
SynonymsG-475
Pregnancy
category
  •  ?
Routes of
administration
Oral[1]
ATC code
Legal status
Legal status
  •  ?
Pharmacokinetic data
Bioavailability83%[1]
MetabolismHepatic
Elimination half-life6.1-11.2 hours[1]
ExcretionRenal[1]
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC13H18N2O3
Molar mass250.294 g/mol
3D model (JSmol)
  (verify)

WikiDoc Resources for Heptabarbital

Articles

Most recent articles on Heptabarbital

Most cited articles on Heptabarbital

Review articles on Heptabarbital

Articles on Heptabarbital in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Heptabarbital

Images of Heptabarbital

Photos of Heptabarbital

Podcasts & MP3s on Heptabarbital

Videos on Heptabarbital

Evidence Based Medicine

Cochrane Collaboration on Heptabarbital

Bandolier on Heptabarbital

TRIP on Heptabarbital

Clinical Trials

Ongoing Trials on Heptabarbital at Clinical Trials.gov

Trial results on Heptabarbital

Clinical Trials on Heptabarbital at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Heptabarbital

NICE Guidance on Heptabarbital

NHS PRODIGY Guidance

FDA on Heptabarbital

CDC on Heptabarbital

Books

Books on Heptabarbital

News

Heptabarbital in the news

Be alerted to news on Heptabarbital

News trends on Heptabarbital

Commentary

Blogs on Heptabarbital

Definitions

Definitions of Heptabarbital

Patient Resources / Community

Patient resources on Heptabarbital

Discussion groups on Heptabarbital

Patient Handouts on Heptabarbital

Directions to Hospitals Treating Heptabarbital

Risk calculators and risk factors for Heptabarbital

Healthcare Provider Resources

Symptoms of Heptabarbital

Causes & Risk Factors for Heptabarbital

Diagnostic studies for Heptabarbital

Treatment of Heptabarbital

Continuing Medical Education (CME)

CME Programs on Heptabarbital

International

Heptabarbital en Espanol

Heptabarbital en Francais

Business

Heptabarbital in the Marketplace

Patents on Heptabarbital

Experimental / Informatics

List of terms related to Heptabarbital

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Heptabarb (INN; Eudan, Medapan, Medomin, Noctyn), also known as heptabarbitone (BAN) or heptabarbital, is a sedative and hypnotic drug of the barbiturate family.[2][3] It was previously used in Europe for the treatment of insomnia from the 1950s onwards, but has since been discontinued.[2][3]

See also

References

  1. 1.0 1.1 1.2 1.3 Breimer DD, de Boer AG (December 1975). "Pharmacokinetics and relative bioavailability of heptabarbital and heptabarbital sodium after oral administration to man". European Journal of Clinical Pharmacology. 9 (2–3): 169–78. doi:10.1007/bf00614014. PMID 9299.
  2. 2.0 2.1 C. R Ganellin; D. J Triggle; F.. Macdonald (1997). Dictionary of pharmacological agents. CRC Press. p. 1003. ISBN 978-0-412-46630-4. Retrieved 26 November 2011.
  3. 3.0 3.1 Index nominum 2000: international drug directory. Taylor & Francis US. 2000. p. 513. ISBN 978-3-88763-075-1. Retrieved 26 November 2011.


Template:GABAAR PAMs


Template:Sedative-stub


Linked-in.jpg